SPC257
Abemaciclib eða lyfjafræðilega viðunandi salt þar af
Status:
VeittApplication date:
25.2.2019Application published:
15.3.2019Grant published:
15.9.2020
Max expiry date:
30.9.2033Medicine name:
VerzeniosMedicine for children:
No
Timeline
Today
25.2.2019Application
15.3.2019Publication
15.9.2020Registration
30.9.2033Expires
Marketing license
IS authorization number:
EU/1/18/1307/001-003; EU/1/18/1307/004-006; EU/1/18/1307/007-009Date:
25.10.2018
Foreign authorization number:
EU/1/18/1307Date:
27.9.2018
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2379528